Ms Julie A Major, PSYD | |
1116 Key St Ste 200, Bellingham, WA 98225-5232 | |
(360) 734-7146 | |
(360) 671-0981 |
Full Name | Ms Julie A Major |
---|---|
Gender | Female |
Speciality | Clinical Psychologist |
Experience | 31 Years |
Location | 1116 Key St Ste 200, Bellingham, Washington |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1770616948 | NPI | - | NPPES |
169367 | Other | WA | L&I PROVIDER ID |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
103TC0700X | Psychologist - Clinical | PY00001860 (Washington) | Primary |
Mailing Address | Practice Location Address |
---|---|
Ms Julie A Major, PSYD 1116 Key St Ste 200, Bellingham, WA 98225-5232 Ph: (360) 734-7146 | Ms Julie A Major, PSYD 1116 Key St Ste 200, Bellingham, WA 98225-5232 Ph: (360) 734-7146 |
News Archive
Onyx Pharmaceuticals, Inc. today announced that the company has begun enrollment in the ASPIRE trial, a Phase 3 international clinical trial evaluating carfilzomib in combination with lenalidomide (Revlimid®) and low dose dexamethasone in patients with relapsed multiple myeloma. The company has an agreement with the U.S. Food and Drug Administration (FDA) on a Special Protocol Assessment (SPA) and received Scientific Advice from the European Medicines Agency (EMA) on the design and planned analysis of the ASPIRE trial.
Most of the time, it takes decades of accumulating genetic errors for a tumor to develop. While this explains the general occurrence of cancer in adults, it leaves a gap in understanding of the cause of pediatric tumors.
Preliminary new research demonstrates for the first time that lutein, an important phytonutrient (plant-based nutrient) that supports eye health, is the predominant carotenoid present in key areas of the infant brain, including areas that regulate overall brain function, cognition, vision, hearing and speech. This new research, supported by Abbott, was presented by Elizabeth Johnson, PhD, a scientist in the Carotenoids and Health Laboratory at Tufts University, at the 16th International Symposium on Carotenoids, in Krakow, Poland.
Orexigen® Therapeutics, Inc. and Takeda Pharmaceutical Company Limited announced today that the United States Food and Drug Administration (FDA) has issued a complete response letter dated January 31, 2011 regarding the New Drug Application for Contrave® (naltrexone HCl/bupropion HCl) extended-release tablets for the treatment of obesity, including weight loss and maintenance of weight loss.
› Verified 3 days ago
Patricia A Marek, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1201 11th Street Suite 201, Bellingham, WA 98225 Phone: 360-647-2808 Fax: 360-752-0037 | |
Dr. Steve Call, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 801 Samish Way, Bellingham, WA 98229 Phone: 425-753-3547 | |
Kathryn Oost, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1140 10th St Ste 203, Bellingham, WA 98225 Phone: 360-603-0518 | |
Nahid Markosian, PH.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 12 Bellwether Way, Suite 223, Bellingham, WA 98225 Phone: 360-255-2505 Fax: 360-255-2504 | |
Dr. Thomas Christopher Portman, PH.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 1118 Finnegan Way, Suite 104, Bellingham, WA 98225 Phone: 360-733-4502 Fax: 360-733-7594 | |
Dr. Cara Joann Anderson, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1155 N State St, Bellingham, WA 98225 Phone: 360-255-2505 Fax: 360-255-2504 | |
Dr. Susan D. Kane-ronning, PH.D. Psychologist Medicare: Medicare Enrolled Practice Location: 1117 Ellis St, Bellingham, WA 98225 Phone: 360-714-8109 Fax: 360-756-8936 |